TG Therapeutics
+$2.52 (+7.39%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.
About TGTX
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.
CEO
Michael Sean Weiss
Employees
272
Headquarters
New York, New York
Founded
1993
TGTX Key Statistics
Market Cap
5.46B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
829.24K
High Today
$36.80
Low Today
$34.39
Open Price
$34.59
Volume
719.46K
52 Week High
$56.74
52 Week Low
$17.67
Analyst Ratings
88%
of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%
TGTX Earnings
-$0.73
-$0.49
-$0.24
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market